Investing.com - NuCana reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
NuCana announced earnings per share of £-0.0015 on revenue of £0.00. Analysts polled by Investing.com anticipated EPS of £-0.0018 on revenue of £0.00.
NuCana shares are down 56.24% from the beginning of the year, still down 67.18% from its 52 week high of £7.83 set on January 13. They are under-performing the Nasdaq which is up 24.09% from the start of the year.
NuCana follows other major Healthcare sector earnings this month
NuCana's report follows an earnings beat by Pfizer on November 2, who reported EPS of £1.34 on revenue of £24.09B, compared to forecasts EPS of £1.08 on revenue of £22.58B.
Novo Nordisk ADR had beat expectations on November 3 with third quarter EPS of £0.8209 on revenue of £5.55B, compared to forecast for EPS of £0.7768 on revenue of £5.39B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar